Cargando…
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada
INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic;...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186449/ https://www.ncbi.nlm.nih.gov/pubmed/37169505 http://dx.doi.org/10.1136/bmjopen-2022-070837 |
_version_ | 1785042560574554112 |
---|---|
author | Ruiz-Burga, Elisa Tariq, Shema Touloumi, Giota Gill, John Nicholls, Emily Jay Sabin, Caroline Mussini, Cristina Meyer, Laurence Volny Anne, Alain Carlander, Christina Grabar, Sophie Jarrin, Inma Van der Valk, Marc Wittkop, Linda Spire, Bruno Pantazis, Nikos Burns, Fiona M Porter, Kholoud |
author_facet | Ruiz-Burga, Elisa Tariq, Shema Touloumi, Giota Gill, John Nicholls, Emily Jay Sabin, Caroline Mussini, Cristina Meyer, Laurence Volny Anne, Alain Carlander, Christina Grabar, Sophie Jarrin, Inma Van der Valk, Marc Wittkop, Linda Spire, Bruno Pantazis, Nikos Burns, Fiona M Porter, Kholoud |
author_sort | Ruiz-Burga, Elisa |
collection | PubMed |
description | INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic; factors associated with access to, and uptake of prevention methods and ART initiation; and the experiences, needs and outcomes of people with recently acquired HIV. METHODS AND ANALYSIS: This longitudinal observational study is recruiting participants aged ≥16 years with documented laboratory evidence of HIV seroconversion from clinics in Canada and six European countries. We will analyse data from medical records, self-administered questionnaires, semistructured interviews and participatory photography. We will assess temporal trends in transmitted drug resistance and viral subtype and examine outcomes following early ART initiation. We will investigate patient-reported outcomes, well-being, and experiences of, knowledge of, and attitudes to HIV preventions, including PrEP. We will analyse qualitative data thematically and triangulate quantitative and qualitative findings. As patient public involvement is central to this work, we have convened a community advisory board (CAB) comprising people living with HIV. ETHICS AND DISSEMINATION: All respective research ethics committees have approval for data to contribute to international collaborations. Written informed consent is required to take part. A dissemination strategy will be developed in collaboration with CAB and the scientific committee. It will include peer-reviewed publications, conference presentations and accessible summaries of findings on the study’s website, social media and via community organisations. |
format | Online Article Text |
id | pubmed-10186449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101864492023-05-17 CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada Ruiz-Burga, Elisa Tariq, Shema Touloumi, Giota Gill, John Nicholls, Emily Jay Sabin, Caroline Mussini, Cristina Meyer, Laurence Volny Anne, Alain Carlander, Christina Grabar, Sophie Jarrin, Inma Van der Valk, Marc Wittkop, Linda Spire, Bruno Pantazis, Nikos Burns, Fiona M Porter, Kholoud BMJ Open HIV/AIDS INTRODUCTION: Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to understand current drivers of the HIV epidemic; factors associated with access to, and uptake of prevention methods and ART initiation; and the experiences, needs and outcomes of people with recently acquired HIV. METHODS AND ANALYSIS: This longitudinal observational study is recruiting participants aged ≥16 years with documented laboratory evidence of HIV seroconversion from clinics in Canada and six European countries. We will analyse data from medical records, self-administered questionnaires, semistructured interviews and participatory photography. We will assess temporal trends in transmitted drug resistance and viral subtype and examine outcomes following early ART initiation. We will investigate patient-reported outcomes, well-being, and experiences of, knowledge of, and attitudes to HIV preventions, including PrEP. We will analyse qualitative data thematically and triangulate quantitative and qualitative findings. As patient public involvement is central to this work, we have convened a community advisory board (CAB) comprising people living with HIV. ETHICS AND DISSEMINATION: All respective research ethics committees have approval for data to contribute to international collaborations. Written informed consent is required to take part. A dissemination strategy will be developed in collaboration with CAB and the scientific committee. It will include peer-reviewed publications, conference presentations and accessible summaries of findings on the study’s website, social media and via community organisations. BMJ Publishing Group 2023-05-11 /pmc/articles/PMC10186449/ /pubmed/37169505 http://dx.doi.org/10.1136/bmjopen-2022-070837 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | HIV/AIDS Ruiz-Burga, Elisa Tariq, Shema Touloumi, Giota Gill, John Nicholls, Emily Jay Sabin, Caroline Mussini, Cristina Meyer, Laurence Volny Anne, Alain Carlander, Christina Grabar, Sophie Jarrin, Inma Van der Valk, Marc Wittkop, Linda Spire, Bruno Pantazis, Nikos Burns, Fiona M Porter, Kholoud CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title | CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title_full | CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title_fullStr | CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title_full_unstemmed | CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title_short | CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada |
title_sort | cascade protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired hiv infection through a multicentre mixed-methods observational study in europe and canada |
topic | HIV/AIDS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186449/ https://www.ncbi.nlm.nih.gov/pubmed/37169505 http://dx.doi.org/10.1136/bmjopen-2022-070837 |
work_keys_str_mv | AT ruizburgaelisa cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT tariqshema cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT touloumigiota cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT gilljohn cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT nichollsemilyjay cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT sabincaroline cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT mussinicristina cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT meyerlaurence cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT volnyannealain cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT carlanderchristina cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT grabarsophie cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT jarrininma cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT vandervalkmarc cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT wittkoplinda cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT spirebruno cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT pantazisnikos cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT burnsfionam cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT porterkholoud cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada AT cascadeprotocolexploringcurrentviralandhostcharacteristicsmeasuringclinicalandpatientreportedoutcomesandunderstandingthelivedexperiencesandneedsofindividualswithrecentlyacquiredhivinfectionthroughamulticentremixedmethodsobservationalstudyineuropeandcanada |